Company / SG&A per Share
Twist Bioscience Corp SG&A per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$4.13
FY2025
5-year range
$2.82 / $4.13
FY2021-FY2025
Trend
+9.7%
vs FY2024
Sector context
#43 of 208
Health Care
What the data says
Twist Bioscience Corp's sg&a per share of $4.13 is higher than 79% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 9 years, ranging from $0.01 in FY2017 to $15556.75 in FY2018.
Based on SEC 10-K filings.
4.13 in FY2025 with a 5-year CAGR of +9.4%. Top quartile in the Health Care sector.
Increased from $3.34 to $4.13 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +1.5%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Sector benchmark
-86.1% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 9.7% year-over-year.
- Ranks #43 out of 208 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2018.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.13 | +9.7% |
| FY2024 | $3.76 | +12.9% |
| FY2023 | $3.34 | -15.6% |
| FY2022 | $3.95 | +40.3% |
| FY2021 | $2.82 | +6.9% |
| FY2020 | $2.64 | -9.7% |
| FY2019 | $2.92 | -100.0% |
| FY2018 | $15556.75 | +144597852.4% |
| FY2017 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026